Crossmark

Could the combination of immunotherapy and target therapy be a potential double edge sword for glioblastoma treatment? A correspondence

Published Online: 2024-03-08

Authors

Jalloh, Mohamed

Kankam, Samuel Berchi

Osifala, Oluwafeyisola
License Information

Text and Data Mining valid from 2024-03-08

Version of Record valid from 2024-03-08
More Information

Article History

Received: 24 February 2024

Revised: 26 February 2024

Accepted: 5 March 2024

First Online: 8 March 2024

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current